

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | dopamine transport (GO:0015872) | 5.92028170 |
| 2 | dopamine biosynthetic process (GO:0042416) | 5.45943267 |
| 3 | synaptic transmission, dopaminergic (GO:0001963) | 5.31101718 |
| 4 | prepulse inhibition (GO:0060134) | 5.17580191 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 4.76275920 |
| 6 | mating behavior (GO:0007617) | 4.74326292 |
| 7 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.57120504 |
| 8 | vocalization behavior (GO:0071625) | 4.53481607 |
| 9 | catecholamine transport (GO:0051937) | 4.52382816 |
| 10 | behavioral response to nicotine (GO:0035095) | 4.46559258 |
| 11 | response to amphetamine (GO:0001975) | 4.43346951 |
| 12 | striatum development (GO:0021756) | 4.34230377 |
| 13 | female mating behavior (GO:0060180) | 4.25249942 |
| 14 | transmission of nerve impulse (GO:0019226) | 4.24008557 |
| 15 | response to histamine (GO:0034776) | 4.22995151 |
| 16 | drinking behavior (GO:0042756) | 4.19748991 |
| 17 | regulation of female receptivity (GO:0045924) | 4.14075071 |
| 18 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.05672066 |
| 19 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.02543748 |
| 20 | regulation of dopamine metabolic process (GO:0042053) | 4.01676039 |
| 21 | regulation of catecholamine metabolic process (GO:0042069) | 4.01676039 |
| 22 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 4.00290807 |
| 23 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 4.00290807 |
| 24 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.99964362 |
| 25 | behavioral response to cocaine (GO:0048148) | 3.99532529 |
| 26 | serotonin metabolic process (GO:0042428) | 3.95200402 |
| 27 | kynurenine metabolic process (GO:0070189) | 3.89808148 |
| 28 | alkaloid metabolic process (GO:0009820) | 3.89300693 |
| 29 | neuron-neuron synaptic transmission (GO:0007270) | 3.88343090 |
| 30 | synaptic vesicle maturation (GO:0016188) | 3.84131592 |
| 31 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.83817727 |
| 32 | indolalkylamine metabolic process (GO:0006586) | 3.82008414 |
| 33 | tryptophan metabolic process (GO:0006568) | 3.80133183 |
| 34 | synaptic vesicle exocytosis (GO:0016079) | 3.76242607 |
| 35 | primary amino compound metabolic process (GO:1901160) | 3.66229331 |
| 36 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.65468674 |
| 37 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.65468674 |
| 38 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.62637831 |
| 39 | indole-containing compound catabolic process (GO:0042436) | 3.59072686 |
| 40 | indolalkylamine catabolic process (GO:0046218) | 3.59072686 |
| 41 | tryptophan catabolic process (GO:0006569) | 3.59072686 |
| 42 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.56072292 |
| 43 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.54501974 |
| 44 | regulation of glutamate secretion (GO:0014048) | 3.54327717 |
| 45 | protein localization to synapse (GO:0035418) | 3.53761120 |
| 46 | response to insecticide (GO:0017085) | 3.52619606 |
| 47 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.51552919 |
| 48 | ATP synthesis coupled proton transport (GO:0015986) | 3.51552919 |
| 49 | neurotransmitter secretion (GO:0007269) | 3.50604411 |
| 50 | response to cocaine (GO:0042220) | 3.48461975 |
| 51 | aggressive behavior (GO:0002118) | 3.48261045 |
| 52 | indole-containing compound metabolic process (GO:0042430) | 3.47524799 |
| 53 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.47363684 |
| 54 | intraspecies interaction between organisms (GO:0051703) | 3.46235147 |
| 55 | social behavior (GO:0035176) | 3.46235147 |
| 56 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.42522757 |
| 57 | regulation of protein kinase A signaling (GO:0010738) | 3.42000168 |
| 58 | response to pheromone (GO:0019236) | 3.39344234 |
| 59 | synaptic transmission, glutamatergic (GO:0035249) | 3.38255753 |
| 60 | auditory behavior (GO:0031223) | 3.37965694 |
| 61 | neurotransmitter transport (GO:0006836) | 3.37725777 |
| 62 | neuronal ion channel clustering (GO:0045161) | 3.37724772 |
| 63 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.36590811 |
| 64 | neurotransmitter biosynthetic process (GO:0042136) | 3.35778817 |
| 65 | glutamate receptor signaling pathway (GO:0007215) | 3.34706338 |
| 66 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.34483720 |
| 67 | regulation of neurotransmitter uptake (GO:0051580) | 3.33762543 |
| 68 | locomotory exploration behavior (GO:0035641) | 3.33673099 |
| 69 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.32917099 |
| 70 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.32909887 |
| 71 | * opioid receptor signaling pathway (GO:0038003) | 3.32698390 |
| 72 | glutamate secretion (GO:0014047) | 3.32202312 |
| 73 | regulation of synapse structural plasticity (GO:0051823) | 3.31108072 |
| 74 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.30020925 |
| 75 | negative regulation of neurotransmitter transport (GO:0051589) | 3.29044428 |
| 76 | protein polyglutamylation (GO:0018095) | 3.25268199 |
| 77 | nucleobase catabolic process (GO:0046113) | 3.25013084 |
| 78 | presynaptic membrane assembly (GO:0097105) | 3.23447179 |
| 79 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.22641017 |
| 80 | regulation of neurotransmitter levels (GO:0001505) | 3.21756599 |
| 81 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.21679888 |
| 82 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.18507551 |
| 83 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.16647848 |
| 84 | multi-organism reproductive behavior (GO:0044705) | 3.16044713 |
| 85 | regulation of uterine smooth muscle contraction (GO:0070472) | 3.15830280 |
| 86 | response to auditory stimulus (GO:0010996) | 3.15298664 |
| 87 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.15129929 |
| 88 | synapse assembly (GO:0007416) | 3.10686272 |
| 89 | regulation of dopamine secretion (GO:0014059) | 3.10597909 |
| 90 | positive regulation of synapse assembly (GO:0051965) | 3.08734495 |
| 91 | response to amine (GO:0014075) | 3.07799068 |
| 92 | anterograde axon cargo transport (GO:0008089) | 3.07652613 |
| 93 | neuron recognition (GO:0008038) | 3.06842966 |
| 94 | catecholamine biosynthetic process (GO:0042423) | 3.06208659 |
| 95 | catechol-containing compound biosynthetic process (GO:0009713) | 3.06208659 |
| 96 | dopamine metabolic process (GO:0042417) | 3.05552040 |
| 97 | gamma-aminobutyric acid transport (GO:0015812) | 3.05334213 |
| 98 | epithelial cilium movement (GO:0003351) | 3.05326662 |
| 99 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.05094432 |
| 100 | regulation of postsynaptic membrane potential (GO:0060078) | 3.04611443 |
| 101 | neuronal action potential propagation (GO:0019227) | 3.02984617 |
| 102 | neuromuscular process controlling posture (GO:0050884) | 3.00969585 |
| 103 | reproductive behavior (GO:0019098) | 2.99463909 |
| 104 | monoamine transport (GO:0015844) | 2.99454645 |
| 105 | postsynaptic membrane organization (GO:0001941) | 2.98885517 |
| 106 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.98366394 |
| 107 | innervation (GO:0060384) | 2.97551722 |
| 108 | positive regulation of neurotransmitter transport (GO:0051590) | 2.96647763 |
| 109 | regulation of collateral sprouting (GO:0048670) | 2.96543440 |
| 110 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.96134763 |
| 111 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.94842420 |
| 112 | long-term memory (GO:0007616) | 2.94652204 |
| 113 | presynaptic membrane organization (GO:0097090) | 2.94575757 |
| 114 | regulation of synaptic vesicle transport (GO:1902803) | 2.93811257 |
| 115 | sulfation (GO:0051923) | 2.93650679 |
| 116 | dendritic spine morphogenesis (GO:0060997) | 2.93367476 |
| 117 | neuronal action potential (GO:0019228) | 2.90381051 |
| 118 | neurofilament cytoskeleton organization (GO:0060052) | 2.90272256 |
| 119 | exploration behavior (GO:0035640) | 2.89998529 |
| 120 | dopamine receptor signaling pathway (GO:0007212) | 2.89314455 |
| 121 | limb bud formation (GO:0060174) | 2.88974018 |
| 122 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.88368161 |
| 123 | regulation of action potential (GO:0098900) | 2.87754722 |
| 124 | membrane hyperpolarization (GO:0060081) | 2.87600066 |
| 125 | otic vesicle formation (GO:0030916) | 2.86810985 |
| 126 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.86762460 |
| 127 | inner ear receptor stereocilium organization (GO:0060122) | 2.86603431 |
| 128 | head development (GO:0060322) | 2.86346575 |
| 129 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.85313492 |
| 130 | fucose catabolic process (GO:0019317) | 2.84661289 |
| 131 | L-fucose metabolic process (GO:0042354) | 2.84661289 |
| 132 | L-fucose catabolic process (GO:0042355) | 2.84661289 |
| 133 | positive regulation of renal sodium excretion (GO:0035815) | 2.84651043 |
| 134 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.83961317 |
| 135 | regulation of sequestering of triglyceride (GO:0010889) | 2.83049750 |
| 136 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.82108895 |
| 137 | pharyngeal system development (GO:0060037) | 2.81504484 |
| 138 | proline transport (GO:0015824) | 2.78731789 |
| 139 | cornea development in camera-type eye (GO:0061303) | 2.77934499 |
| 140 | negative chemotaxis (GO:0050919) | 2.77797696 |
| 141 | regulation of neurotransmitter transport (GO:0051588) | 2.77784708 |
| 142 | cell proliferation in forebrain (GO:0021846) | 2.76964748 |
| 143 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.76874702 |
| 144 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.76874702 |
| 145 | NADH dehydrogenase complex assembly (GO:0010257) | 2.76874702 |
| 146 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.76730372 |
| 147 | detection of light stimulus involved in visual perception (GO:0050908) | 2.76730372 |
| 148 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.69362315 |
| 149 | sequestering of actin monomers (GO:0042989) | 2.65467864 |
| 150 | cellular response to sterol (GO:0036315) | 2.65322810 |
| 151 | retinal ganglion cell axon guidance (GO:0031290) | 2.64307756 |
| 152 | cellular response to cholesterol (GO:0071397) | 2.62461755 |
| 153 | thalamus development (GO:0021794) | 2.60702981 |
| 154 | protein complex biogenesis (GO:0070271) | 2.60431883 |
| 155 | somite development (GO:0061053) | 2.59942137 |
| 156 | neurotransmitter catabolic process (GO:0042135) | 2.58429138 |
| 157 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.56639913 |
| 158 | nephron epithelium morphogenesis (GO:0072088) | 2.55012961 |
| 159 | nephron tubule morphogenesis (GO:0072078) | 2.55012961 |
| 160 | resolution of meiotic recombination intermediates (GO:0000712) | 2.54221031 |
| 161 | parturition (GO:0007567) | 2.51992205 |
| 162 | negative regulation of multicellular organism growth (GO:0040015) | 2.49517923 |
| 163 | nonmotile primary cilium assembly (GO:0035058) | 2.47934640 |
| 164 | positive regulation of action potential (GO:0045760) | 2.46968814 |
| 165 | amine catabolic process (GO:0009310) | 2.44210659 |
| 166 | cellular biogenic amine catabolic process (GO:0042402) | 2.44210659 |
| 167 | startle response (GO:0001964) | 2.43740377 |
| 168 | photoreceptor cell development (GO:0042461) | 2.43294895 |
| 169 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.40398875 |
| 170 | cilium movement (GO:0003341) | 2.39551924 |
| 171 | tachykinin receptor signaling pathway (GO:0007217) | 2.39206058 |
| 172 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.38236426 |
| 173 | anterograde synaptic vesicle transport (GO:0048490) | 2.37270998 |
| 174 | spinal cord motor neuron differentiation (GO:0021522) | 2.37183521 |
| 175 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.37045177 |
| 176 | negative regulation of axon guidance (GO:1902668) | 2.36070713 |
| 177 | axonal fasciculation (GO:0007413) | 2.35373676 |
| 178 | phasic smooth muscle contraction (GO:0014821) | 2.34765896 |
| 179 | regulation of gene silencing by RNA (GO:0060966) | 2.34757055 |
| 180 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.34757055 |
| 181 | regulation of gene silencing by miRNA (GO:0060964) | 2.34757055 |
| 182 | regulation of telomere maintenance (GO:0032204) | 2.34636064 |
| 183 | pituitary gland development (GO:0021983) | 2.34222606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.70432829 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.75688799 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.98970582 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.93235550 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.90583382 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.83591029 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.60312433 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.52363407 |
| 9 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46795957 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.45261104 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.42691004 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.42691004 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.42327426 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.36595320 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.35663136 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.34700641 |
| 17 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.31527381 |
| 18 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.27982934 |
| 19 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.21507346 |
| 20 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.21251527 |
| 21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.16211833 |
| 22 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.15890163 |
| 23 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.15347760 |
| 24 | EWS_26573619_Chip-Seq_HEK293_Human | 2.10332777 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.09350272 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.06791625 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.05130376 |
| 28 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.02762079 |
| 29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.97746358 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.92875729 |
| 31 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.90315152 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.90007123 |
| 33 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.86061292 |
| 34 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.83113640 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.81086576 |
| 36 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.78602035 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.78561726 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.78317176 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75493399 |
| 40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.71139278 |
| 41 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.67731573 |
| 42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.64866748 |
| 43 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.64522097 |
| 44 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.59967220 |
| 45 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.57052142 |
| 46 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.56211588 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.55994354 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.55698120 |
| 49 | FUS_26573619_Chip-Seq_HEK293_Human | 1.54392115 |
| 50 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.54279488 |
| 51 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.52133657 |
| 52 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.50820682 |
| 53 | VDR_22108803_ChIP-Seq_LS180_Human | 1.49996300 |
| 54 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.46830625 |
| 55 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.45916169 |
| 56 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.45859078 |
| 57 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.44674739 |
| 58 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.42647583 |
| 59 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.42201592 |
| 60 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41811613 |
| 61 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.41365536 |
| 62 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.39052183 |
| 63 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38296684 |
| 64 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.37918398 |
| 65 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37918398 |
| 66 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.36940358 |
| 67 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.36670884 |
| 68 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.36398151 |
| 69 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.36365677 |
| 70 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.35480322 |
| 71 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.32424449 |
| 72 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.32337937 |
| 73 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.29684713 |
| 74 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.29684713 |
| 75 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.29359713 |
| 76 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25949782 |
| 77 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.25443324 |
| 78 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.24508022 |
| 79 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.24415302 |
| 80 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.24243927 |
| 81 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.23919263 |
| 82 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.23878593 |
| 83 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.23356189 |
| 84 | STAT3_23295773_ChIP-Seq_U87_Human | 1.23039459 |
| 85 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.21981660 |
| 86 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.21908099 |
| 87 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.21257479 |
| 88 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.21191656 |
| 89 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.17932375 |
| 90 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.17781363 |
| 91 | JUN_21703547_ChIP-Seq_K562_Human | 1.16754582 |
| 92 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16276400 |
| 93 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15765656 |
| 94 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.15651869 |
| 95 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.15651869 |
| 96 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14955152 |
| 97 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.14041148 |
| 98 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.13491980 |
| 99 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.13437531 |
| 100 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.13215305 |
| 101 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12562828 |
| 102 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.12560568 |
| 103 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.11724038 |
| 104 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.11071934 |
| 105 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11024115 |
| 106 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.10197924 |
| 107 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.09989492 |
| 108 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.09150808 |
| 109 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.08803517 |
| 110 | KDM2B_26808549_Chip-Seq_REH_Human | 1.05327261 |
| 111 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.04216867 |
| 112 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.03563463 |
| 113 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.03266591 |
| 114 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.02992745 |
| 115 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02150483 |
| 116 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.02142473 |
| 117 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02125849 |
| 118 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01566520 |
| 119 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01510049 |
| 120 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.00716375 |
| 121 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00640510 |
| 122 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99183528 |
| 123 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99154448 |
| 124 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.98272432 |
| 125 | * TP53_22573176_ChIP-Seq_HFKS_Human | 0.97977154 |
| 126 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.97302339 |
| 127 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97289868 |
| 128 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.96340897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.78412991 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.95713690 |
| 3 | MP0001529_abnormal_vocalization | 3.51329190 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.29966942 |
| 5 | * MP0009745_abnormal_behavioral_response | 3.26297009 |
| 6 | MP0006276_abnormal_autonomic_nervous | 3.13379438 |
| 7 | MP0001905_abnormal_dopamine_level | 3.13285840 |
| 8 | MP0002822_catalepsy | 3.00825852 |
| 9 | MP0009046_muscle_twitch | 2.97287017 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.83898043 |
| 11 | MP0005645_abnormal_hypothalamus_physiol | 2.78125481 |
| 12 | MP0001984_abnormal_olfaction | 2.76664937 |
| 13 | * MP0002063_abnormal_learning/memory/cond | 2.75760345 |
| 14 | MP0002064_seizures | 2.72813345 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.64703691 |
| 16 | MP0001486_abnormal_startle_reflex | 2.61830739 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.58294993 |
| 18 | MP0005646_abnormal_pituitary_gland | 2.50459670 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.38402021 |
| 20 | MP0004133_heterotaxia | 2.37606986 |
| 21 | MP0005499_abnormal_olfactory_system | 2.34459392 |
| 22 | MP0005394_taste/olfaction_phenotype | 2.34459392 |
| 23 | MP0003122_maternal_imprinting | 2.27257201 |
| 24 | MP0001501_abnormal_sleep_pattern | 2.18270659 |
| 25 | MP0005379_endocrine/exocrine_gland_phen | 2.16021856 |
| 26 | MP0002272_abnormal_nervous_system | 2.15225487 |
| 27 | MP0002736_abnormal_nociception_after | 2.06369125 |
| 28 | MP0002557_abnormal_social/conspecific_i | 2.02848391 |
| 29 | MP0008877_abnormal_DNA_methylation | 2.00841556 |
| 30 | MP0006292_abnormal_olfactory_placode | 1.98569208 |
| 31 | MP0002734_abnormal_mechanical_nocicepti | 1.97624607 |
| 32 | MP0002653_abnormal_ependyma_morphology | 1.97163694 |
| 33 | MP0001188_hyperpigmentation | 1.96979114 |
| 34 | MP0004924_abnormal_behavior | 1.94819459 |
| 35 | MP0005386_behavior/neurological_phenoty | 1.94819459 |
| 36 | MP0004270_analgesia | 1.92147765 |
| 37 | MP0002067_abnormal_sensory_capabilities | 1.85497889 |
| 38 | MP0006072_abnormal_retinal_apoptosis | 1.80923664 |
| 39 | MP0002735_abnormal_chemical_nociception | 1.78006569 |
| 40 | MP0001502_abnormal_circadian_rhythm | 1.74016238 |
| 41 | MP0003011_delayed_dark_adaptation | 1.71200191 |
| 42 | MP0008872_abnormal_physiological_respon | 1.70344592 |
| 43 | MP0002733_abnormal_thermal_nociception | 1.66233333 |
| 44 | * MP0001970_abnormal_pain_threshold | 1.63147917 |
| 45 | MP0005409_darkened_coat_color | 1.61657951 |
| 46 | MP0003283_abnormal_digestive_organ | 1.61538799 |
| 47 | MP0003195_calcinosis | 1.59583850 |
| 48 | MP0004145_abnormal_muscle_electrophysio | 1.58245463 |
| 49 | MP0003787_abnormal_imprinting | 1.58159652 |
| 50 | MP0004142_abnormal_muscle_tone | 1.52627846 |
| 51 | MP0002928_abnormal_bile_duct | 1.49352513 |
| 52 | MP0004742_abnormal_vestibular_system | 1.48216569 |
| 53 | MP0004147_increased_porphyrin_level | 1.47622104 |
| 54 | MP0005253_abnormal_eye_physiology | 1.46830779 |
| 55 | MP0005248_abnormal_Harderian_gland | 1.45286164 |
| 56 | MP0002184_abnormal_innervation | 1.44350279 |
| 57 | MP0001346_abnormal_lacrimal_gland | 1.43941869 |
| 58 | MP0000566_synostosis | 1.43569105 |
| 59 | MP0002163_abnormal_gland_morphology | 1.42994500 |
| 60 | MP0002751_abnormal_autonomic_nervous | 1.33263976 |
| 61 | MP0000778_abnormal_nervous_system | 1.26665587 |
| 62 | MP0003942_abnormal_urinary_system | 1.25569192 |
| 63 | MP0003119_abnormal_digestive_system | 1.24989303 |
| 64 | MP0003937_abnormal_limbs/digits/tail_de | 1.24245901 |
| 65 | MP0000372_irregular_coat_pigmentation | 1.23209728 |
| 66 | MP0008789_abnormal_olfactory_epithelium | 1.22563273 |
| 67 | MP0000049_abnormal_middle_ear | 1.21617265 |
| 68 | MP0002837_dystrophic_cardiac_calcinosis | 1.21131928 |
| 69 | MP0003890_abnormal_embryonic-extraembry | 1.19539676 |
| 70 | MP0000631_abnormal_neuroendocrine_gland | 1.19225172 |
| 71 | MP0002938_white_spotting | 1.18808072 |
| 72 | MP0001986_abnormal_taste_sensitivity | 1.17930175 |
| 73 | MP0003938_abnormal_ear_development | 1.17515208 |
| 74 | MP0008569_lethality_at_weaning | 1.16621751 |
| 75 | * MP0002066_abnormal_motor_capabilities/c | 1.12041678 |
| 76 | MP0003879_abnormal_hair_cell | 1.11304808 |
| 77 | MP0005084_abnormal_gallbladder_morpholo | 1.10871610 |
| 78 | MP0004130_abnormal_muscle_cell | 1.10078403 |
| 79 | MP0005535_abnormal_body_temperature | 1.07248904 |
| 80 | MP0005187_abnormal_penis_morphology | 1.04631143 |
| 81 | MP0002882_abnormal_neuron_morphology | 1.03742494 |
| 82 | MP0003941_abnormal_skin_development | 0.99791466 |
| 83 | MP0002876_abnormal_thyroid_physiology | 0.98764893 |
| 84 | MP0001664_abnormal_digestion | 0.98354576 |
| 85 | MP0001177_atelectasis | 0.97215545 |
| 86 | MP0003123_paternal_imprinting | 0.96665364 |
| 87 | MP0002102_abnormal_ear_morphology | 0.96607159 |
| 88 | MP0005195_abnormal_posterior_eye | 0.96477445 |
| 89 | MP0008875_abnormal_xenobiotic_pharmacok | 0.95967848 |
| 90 | MP0002069_abnormal_eating/drinking_beha | 0.93912321 |
| 91 | MP0000955_abnormal_spinal_cord | 0.93584895 |
| 92 | MP0004811_abnormal_neuron_physiology | 0.93495469 |
| 93 | MP0002909_abnormal_adrenal_gland | 0.92473107 |
| 94 | MP0003252_abnormal_bile_duct | 0.91942044 |
| 95 | MP0008995_early_reproductive_senescence | 0.91204945 |
| 96 | MP0002160_abnormal_reproductive_system | 0.91055889 |
| 97 | MP0009250_abnormal_appendicular_skeleto | 0.90673681 |
| 98 | MP0003878_abnormal_ear_physiology | 0.88676378 |
| 99 | MP0005377_hearing/vestibular/ear_phenot | 0.88676378 |
| 100 | MP0004134_abnormal_chest_morphology | 0.88277151 |
| 101 | MP0003861_abnormal_nervous_system | 0.88036193 |
| 102 | MP0001293_anophthalmia | 0.86022854 |
| 103 | MP0001963_abnormal_hearing_physiology | 0.84948028 |
| 104 | MP0005551_abnormal_eye_electrophysiolog | 0.84753143 |
| 105 | MP0000751_myopathy | 0.84659399 |
| 106 | MP0004215_abnormal_myocardial_fiber | 0.83103473 |
| 107 | MP0003121_genomic_imprinting | 0.82452871 |
| 108 | MP0000681_abnormal_thyroid_gland | 0.79853681 |
| 109 | MP0000569_abnormal_digit_pigmentation | 0.79831185 |
| 110 | MP0004885_abnormal_endolymph | 0.79351779 |
| 111 | MP0000538_abnormal_urinary_bladder | 0.79308535 |
| 112 | MP0003690_abnormal_glial_cell | 0.79296771 |
| 113 | MP0003136_yellow_coat_color | 0.78563213 |
| 114 | MP0000647_abnormal_sebaceous_gland | 0.78065258 |
| 115 | MP0005171_absent_coat_pigmentation | 0.78050292 |
| 116 | MP0005389_reproductive_system_phenotype | 0.77581744 |
| 117 | MP0008874_decreased_physiological_sensi | 0.76449134 |
| 118 | MP0010386_abnormal_urinary_bladder | 0.76045275 |
| 119 | MP0009697_abnormal_copulation | 0.75485791 |
| 120 | MP0002277_abnormal_respiratory_mucosa | 0.74344440 |
| 121 | MP0002332_abnormal_exercise_endurance | 0.73669602 |
| 122 | MP0003633_abnormal_nervous_system | 0.73640611 |
| 123 | MP0000026_abnormal_inner_ear | 0.72755948 |
| 124 | MP0002152_abnormal_brain_morphology | 0.70465490 |
| 125 | MP0003631_nervous_system_phenotype | 0.69920905 |
| 126 | MP0001485_abnormal_pinna_reflex | 0.67106322 |
| 127 | MP0002752_abnormal_somatic_nervous | 0.66901075 |
| 128 | MP0002229_neurodegeneration | 0.63321758 |
| 129 | MP0001881_abnormal_mammary_gland | 0.63320076 |
| 130 | MP0002090_abnormal_vision | 0.63065719 |
| 131 | MP0004858_abnormal_nervous_system | 0.62927073 |
| 132 | MP0004883_abnormal_blood_vessel | 0.61853887 |
| 133 | MP0002638_abnormal_pupillary_reflex | 0.56736428 |
| 134 | MP0004272_abnormal_basement_membrane | 0.54691403 |
| 135 | MP0009780_abnormal_chondrocyte_physiolo | 0.53715610 |
| 136 | MP0004085_abnormal_heartbeat | 0.53698592 |
| 137 | MP0002254_reproductive_system_inflammat | 0.51176085 |
| 138 | MP0003632_abnormal_nervous_system | 0.50490553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Limb dystonia (HP:0002451) | 8.03568147 |
| 2 | Focal motor seizures (HP:0011153) | 6.39395611 |
| 3 | Myokymia (HP:0002411) | 4.96421757 |
| 4 | Visual hallucinations (HP:0002367) | 4.71835765 |
| 5 | Focal seizures (HP:0007359) | 4.48875819 |
| 6 | True hermaphroditism (HP:0010459) | 4.42635504 |
| 7 | Pancreatic fibrosis (HP:0100732) | 4.38272374 |
| 8 | Febrile seizures (HP:0002373) | 4.19984165 |
| 9 | Pancreatic cysts (HP:0001737) | 3.98199988 |
| 10 | Absent/shortened dynein arms (HP:0200106) | 3.86654047 |
| 11 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.86654047 |
| 12 | Abnormal ciliary motility (HP:0012262) | 3.74815101 |
| 13 | Genetic anticipation (HP:0003743) | 3.63508015 |
| 14 | Congenital stationary night blindness (HP:0007642) | 3.57585274 |
| 15 | Failure to thrive in infancy (HP:0001531) | 3.50336337 |
| 16 | Broad-based gait (HP:0002136) | 3.40097530 |
| 17 | Epileptic encephalopathy (HP:0200134) | 3.39896527 |
| 18 | Fetal akinesia sequence (HP:0001989) | 3.36352056 |
| 19 | Pendular nystagmus (HP:0012043) | 3.35008566 |
| 20 | Abnormal hair whorl (HP:0010721) | 3.20874224 |
| 21 | Generalized tonic-clonic seizures (HP:0002069) | 3.19195243 |
| 22 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.12376813 |
| 23 | Oligomenorrhea (HP:0000876) | 3.05847831 |
| 24 | Absence seizures (HP:0002121) | 3.04743971 |
| 25 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.03946096 |
| 26 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.03946096 |
| 27 | Hypokinesia (HP:0002375) | 2.98839542 |
| 28 | Atonic seizures (HP:0010819) | 2.94850956 |
| 29 | Progressive inability to walk (HP:0002505) | 2.87432274 |
| 30 | Nephronophthisis (HP:0000090) | 2.87041630 |
| 31 | Type II lissencephaly (HP:0007260) | 2.85998160 |
| 32 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.83294664 |
| 33 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.83294664 |
| 34 | Progressive cerebellar ataxia (HP:0002073) | 2.82201532 |
| 35 | Abnormality of the labia minora (HP:0012880) | 2.79799966 |
| 36 | Dialeptic seizures (HP:0011146) | 2.78356245 |
| 37 | Cerebellar dysplasia (HP:0007033) | 2.72330961 |
| 38 | Hypothermia (HP:0002045) | 2.71886124 |
| 39 | Cystic liver disease (HP:0006706) | 2.68347371 |
| 40 | Keratoconus (HP:0000563) | 2.68118346 |
| 41 | Increased corneal curvature (HP:0100692) | 2.68118346 |
| 42 | Hyperventilation (HP:0002883) | 2.66887097 |
| 43 | Gait imbalance (HP:0002141) | 2.66755349 |
| 44 | Abolished electroretinogram (ERG) (HP:0000550) | 2.64427685 |
| 45 | Sclerocornea (HP:0000647) | 2.61761413 |
| 46 | Diminished movement (HP:0002374) | 2.60491722 |
| 47 | Colon cancer (HP:0003003) | 2.58990411 |
| 48 | Osteomalacia (HP:0002749) | 2.57602812 |
| 49 | Fair hair (HP:0002286) | 2.56439474 |
| 50 | Abnormality of the corticospinal tract (HP:0002492) | 2.53400616 |
| 51 | Gaze-evoked nystagmus (HP:0000640) | 2.51811438 |
| 52 | Vaginal atresia (HP:0000148) | 2.49249125 |
| 53 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.48371849 |
| 54 | Congenital primary aphakia (HP:0007707) | 2.48083794 |
| 55 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.48044848 |
| 56 | Furrowed tongue (HP:0000221) | 2.46273606 |
| 57 | Genital tract atresia (HP:0001827) | 2.45872926 |
| 58 | Blue irides (HP:0000635) | 2.45828736 |
| 59 | Medial flaring of the eyebrow (HP:0010747) | 2.44939431 |
| 60 | Anxiety (HP:0000739) | 2.44380248 |
| 61 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.44315647 |
| 62 | Anencephaly (HP:0002323) | 2.43793641 |
| 63 | Parakeratosis (HP:0001036) | 2.40206660 |
| 64 | Sleep apnea (HP:0010535) | 2.39246752 |
| 65 | Abnormality of the renal medulla (HP:0100957) | 2.37953553 |
| 66 | Nephrogenic diabetes insipidus (HP:0009806) | 2.37946765 |
| 67 | Chorioretinal atrophy (HP:0000533) | 2.33933949 |
| 68 | Large for gestational age (HP:0001520) | 2.32956411 |
| 69 | Generalized hypopigmentation of hair (HP:0011358) | 2.32065554 |
| 70 | Concave nail (HP:0001598) | 2.31429037 |
| 71 | Decreased central vision (HP:0007663) | 2.30510562 |
| 72 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.30277952 |
| 73 | Gonadotropin excess (HP:0000837) | 2.30214912 |
| 74 | Attenuation of retinal blood vessels (HP:0007843) | 2.30102492 |
| 75 | Abnormality of the renal cortex (HP:0011035) | 2.30082108 |
| 76 | Torticollis (HP:0000473) | 2.29283201 |
| 77 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.29090526 |
| 78 | 3-Methylglutaconic aciduria (HP:0003535) | 2.26180923 |
| 79 | Neuroendocrine neoplasm (HP:0100634) | 2.26172547 |
| 80 | Pheochromocytoma (HP:0002666) | 2.25415562 |
| 81 | Short tibia (HP:0005736) | 2.22098587 |
| 82 | Hemiparesis (HP:0001269) | 2.21973204 |
| 83 | Polyphagia (HP:0002591) | 2.21110350 |
| 84 | Male pseudohermaphroditism (HP:0000037) | 2.20667401 |
| 85 | Renal cortical cysts (HP:0000803) | 2.20423411 |
| 86 | Agitation (HP:0000713) | 2.19947055 |
| 87 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.19833049 |
| 88 | Abnormality of alanine metabolism (HP:0010916) | 2.19833049 |
| 89 | Hyperalaninemia (HP:0003348) | 2.19833049 |
| 90 | Ependymoma (HP:0002888) | 2.19425747 |
| 91 | Epidermoid cyst (HP:0200040) | 2.18720847 |
| 92 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.17564065 |
| 93 | Abnormal eating behavior (HP:0100738) | 2.17547736 |
| 94 | Depression (HP:0000716) | 2.16694710 |
| 95 | Scanning speech (HP:0002168) | 2.16241876 |
| 96 | Hypoventilation (HP:0002791) | 2.14908524 |
| 97 | Lower limb amyotrophy (HP:0007210) | 2.14908419 |
| 98 | Methylmalonic acidemia (HP:0002912) | 2.13704168 |
| 99 | Urinary urgency (HP:0000012) | 2.13258741 |
| 100 | Rhinitis (HP:0012384) | 2.11308123 |
| 101 | Focal dystonia (HP:0004373) | 2.09904895 |
| 102 | Absent speech (HP:0001344) | 2.09442745 |
| 103 | Submucous cleft hard palate (HP:0000176) | 2.09417718 |
| 104 | Abnormal pupillary function (HP:0007686) | 2.07051104 |
| 105 | Poor coordination (HP:0002370) | 2.06967577 |
| 106 | Specific learning disability (HP:0001328) | 2.06952187 |
| 107 | Mutism (HP:0002300) | 2.06624854 |
| 108 | Truncal ataxia (HP:0002078) | 2.06275637 |
| 109 | Brushfield spots (HP:0001088) | 2.04372090 |
| 110 | Abnormal biliary tract physiology (HP:0012439) | 2.04003082 |
| 111 | Bile duct proliferation (HP:0001408) | 2.04003082 |
| 112 | Chronic hepatic failure (HP:0100626) | 2.02642027 |
| 113 | Partial agenesis of the corpus callosum (HP:0001338) | 2.02404830 |
| 114 | Acute necrotizing encephalopathy (HP:0006965) | 1.99845961 |
| 115 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.97955217 |
| 116 | Aplasia of the phalanges of the hand (HP:0009802) | 1.97955217 |
| 117 | Aplasia involving bones of the extremities (HP:0009825) | 1.97955217 |
| 118 | Narrow nasal bridge (HP:0000446) | 1.97167254 |
| 119 | Aplasia of the musculature (HP:0100854) | 1.96820158 |
| 120 | Optic nerve hypoplasia (HP:0000609) | 1.96628569 |
| 121 | Poor suck (HP:0002033) | 1.96625551 |
| 122 | Lissencephaly (HP:0001339) | 1.96132536 |
| 123 | Craniofacial dystonia (HP:0012179) | 1.95101116 |
| 124 | Abnormality of incisor morphology (HP:0011063) | 1.94671656 |
| 125 | Prolonged QT interval (HP:0001657) | 1.93034733 |
| 126 | Progressive macrocephaly (HP:0004481) | 1.91946248 |
| 127 | Drooling (HP:0002307) | 1.91511187 |
| 128 | Excessive salivation (HP:0003781) | 1.91511187 |
| 129 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.91036775 |
| 130 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.89444098 |
| 131 | Poor eye contact (HP:0000817) | 1.89196586 |
| 132 | Potter facies (HP:0002009) | 1.88811212 |
| 133 | Facial shape deformation (HP:0011334) | 1.88811212 |
| 134 | Inability to walk (HP:0002540) | 1.88538516 |
| 135 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.88062359 |
| 136 | Optic disc pallor (HP:0000543) | 1.87918183 |
| 137 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.87813037 |
| 138 | Increased CSF lactate (HP:0002490) | 1.86840687 |
| 139 | Postaxial foot polydactyly (HP:0001830) | 1.85499725 |
| 140 | Pachygyria (HP:0001302) | 1.84972132 |
| 141 | Congenital hepatic fibrosis (HP:0002612) | 1.83847186 |
| 142 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.83434423 |
| 143 | Bradykinesia (HP:0002067) | 1.83294729 |
| 144 | Incomplete penetrance (HP:0003829) | 1.82079856 |
| 145 | Septo-optic dysplasia (HP:0100842) | 1.80682204 |
| 146 | Mitochondrial inheritance (HP:0001427) | 1.80560331 |
| 147 | Horizontal nystagmus (HP:0000666) | 1.80302078 |
| 148 | Molar tooth sign on MRI (HP:0002419) | 1.79968493 |
| 149 | Abnormality of midbrain morphology (HP:0002418) | 1.79968493 |
| 150 | Renal Fanconi syndrome (HP:0001994) | 1.78075066 |
| 151 | Homocystinuria (HP:0002156) | 1.77797181 |
| 152 | Abnormality of homocysteine metabolism (HP:0010919) | 1.77797181 |
| 153 | Esotropia (HP:0000565) | 1.76812801 |
| 154 | Rigidity (HP:0002063) | 1.76348863 |
| 155 | Fibular aplasia (HP:0002990) | 1.75664036 |
| 156 | Postaxial hand polydactyly (HP:0001162) | 1.74243742 |
| 157 | Ankle clonus (HP:0011448) | 1.73950808 |
| 158 | Distal lower limb muscle weakness (HP:0009053) | 1.73882537 |
| 159 | Severe muscular hypotonia (HP:0006829) | 1.72707959 |
| 160 | Abnormal number of erythroid precursors (HP:0012131) | 1.70927910 |
| 161 | Dysphonia (HP:0001618) | 1.70656033 |
| 162 | Abnormal EKG (HP:0003115) | 1.70595194 |
| 163 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.69901468 |
| 164 | Methylmalonic aciduria (HP:0012120) | 1.69255035 |
| 165 | Small hand (HP:0200055) | 1.69133313 |
| 166 | Glioma (HP:0009733) | 1.67068885 |
| 167 | Intestinal atresia (HP:0011100) | 1.66820429 |
| 168 | Increased hepatocellular lipid droplets (HP:0006565) | 1.66529340 |
| 169 | Astrocytoma (HP:0009592) | 1.65925168 |
| 170 | Abnormality of the astrocytes (HP:0100707) | 1.65925168 |
| 171 | Preaxial hand polydactyly (HP:0001177) | 1.63932162 |
| 172 | Acute encephalopathy (HP:0006846) | 1.63634049 |
| 173 | Multicystic kidney dysplasia (HP:0000003) | 1.63053696 |
| 174 | Adrenal hypoplasia (HP:0000835) | 1.62292126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.28350271 |
| 2 | MAP3K12 | 3.96875217 |
| 3 | FRK | 3.90668538 |
| 4 | WNK3 | 3.45642392 |
| 5 | CASK | 3.41450622 |
| 6 | EPHA4 | 3.35930682 |
| 7 | MAPKAPK5 | 2.60869956 |
| 8 | MAP2K7 | 2.59648233 |
| 9 | GRK1 | 2.59393127 |
| 10 | SIK3 | 2.52836249 |
| 11 | MAP3K9 | 2.48937741 |
| 12 | MAP3K13 | 2.43043780 |
| 13 | MAP4K2 | 2.39613636 |
| 14 | TNIK | 2.35414029 |
| 15 | MAP3K4 | 2.17892002 |
| 16 | MINK1 | 2.10921136 |
| 17 | SIK2 | 2.02187491 |
| 18 | BMPR1B | 1.91622607 |
| 19 | MKNK2 | 1.86535531 |
| 20 | NTRK2 | 1.84475330 |
| 21 | TLK1 | 1.80692590 |
| 22 | DYRK2 | 1.78086532 |
| 23 | MAP2K4 | 1.76075428 |
| 24 | NUAK1 | 1.74639454 |
| 25 | PRKD3 | 1.74391763 |
| 26 | TAF1 | 1.73905867 |
| 27 | BRD4 | 1.68999502 |
| 28 | PNCK | 1.68981669 |
| 29 | GRK5 | 1.66221288 |
| 30 | EPHA2 | 1.62749981 |
| 31 | BCKDK | 1.62308866 |
| 32 | RIPK4 | 1.61572040 |
| 33 | MARK1 | 1.57947298 |
| 34 | PLK2 | 1.52422619 |
| 35 | TNK2 | 1.52219672 |
| 36 | GRK7 | 1.50004914 |
| 37 | ARAF | 1.47928185 |
| 38 | ACVR1B | 1.46145685 |
| 39 | BMPR2 | 1.32487500 |
| 40 | PRPF4B | 1.32253852 |
| 41 | CAMK2A | 1.32114740 |
| 42 | CAMK2B | 1.27271293 |
| 43 | NTRK1 | 1.24750559 |
| 44 | CAMKK2 | 1.24607949 |
| 45 | CDK5 | 1.22431311 |
| 46 | FGFR2 | 1.21939245 |
| 47 | PRKCG | 1.20211667 |
| 48 | NEK6 | 1.16399653 |
| 49 | CSNK1A1L | 1.15539473 |
| 50 | MKNK1 | 1.15007522 |
| 51 | FES | 1.14508269 |
| 52 | TYRO3 | 1.13400114 |
| 53 | LATS2 | 1.10152800 |
| 54 | WNK4 | 1.08039517 |
| 55 | MAPK13 | 1.06576670 |
| 56 | SGK2 | 1.06548336 |
| 57 | CAMK2D | 1.06422815 |
| 58 | VRK1 | 1.03504809 |
| 59 | TAOK3 | 0.99830258 |
| 60 | CAMK2G | 0.98059019 |
| 61 | VRK2 | 0.90350701 |
| 62 | UHMK1 | 0.89858967 |
| 63 | SGK223 | 0.89580247 |
| 64 | SGK494 | 0.89580247 |
| 65 | FER | 0.86184529 |
| 66 | CAMKK1 | 0.83466278 |
| 67 | EPHB2 | 0.81375401 |
| 68 | TGFBR1 | 0.80383072 |
| 69 | OXSR1 | 0.79738355 |
| 70 | STK38 | 0.77838885 |
| 71 | FGR | 0.76988096 |
| 72 | AKT3 | 0.76954933 |
| 73 | CAMK1 | 0.76921246 |
| 74 | PAK3 | 0.76133718 |
| 75 | PRKCE | 0.75728564 |
| 76 | CDK18 | 0.75579973 |
| 77 | PAK6 | 0.74306973 |
| 78 | SGK1 | 0.74121614 |
| 79 | MUSK | 0.73652095 |
| 80 | TSSK6 | 0.72214375 |
| 81 | ZAK | 0.71826194 |
| 82 | LMTK2 | 0.71646057 |
| 83 | DYRK3 | 0.71424727 |
| 84 | CSNK1G2 | 0.71099315 |
| 85 | ADRBK1 | 0.69646283 |
| 86 | KSR1 | 0.69534270 |
| 87 | INSRR | 0.68872536 |
| 88 | CDK15 | 0.68668207 |
| 89 | BCR | 0.68081514 |
| 90 | PRKCI | 0.67972930 |
| 91 | TRIM28 | 0.67893090 |
| 92 | SGK3 | 0.67598547 |
| 93 | CDK14 | 0.67132856 |
| 94 | CDK19 | 0.67100298 |
| 95 | ERBB3 | 0.65285433 |
| 96 | * ADRBK2 | 0.63872861 |
| 97 | PRKCH | 0.62492119 |
| 98 | PRKCZ | 0.59651499 |
| 99 | CSNK1G3 | 0.59583498 |
| 100 | STK16 | 0.58263479 |
| 101 | KSR2 | 0.58196284 |
| 102 | CDK11A | 0.56326410 |
| 103 | MAP2K1 | 0.56103819 |
| 104 | STK39 | 0.55104981 |
| 105 | PLK3 | 0.54983767 |
| 106 | PBK | 0.54971962 |
| 107 | TXK | 0.54911968 |
| 108 | PINK1 | 0.54868236 |
| 109 | PHKG1 | 0.54537968 |
| 110 | PHKG2 | 0.54537968 |
| 111 | TAOK1 | 0.53790545 |
| 112 | NME1 | 0.53248893 |
| 113 | STK11 | 0.52868277 |
| 114 | MAP3K1 | 0.52791458 |
| 115 | LATS1 | 0.52658498 |
| 116 | PTK2B | 0.52395967 |
| 117 | MAPK15 | 0.52099366 |
| 118 | CDC42BPA | 0.51653595 |
| 119 | DYRK1A | 0.50885039 |
| 120 | YES1 | 0.50182975 |
| 121 | CSNK1A1 | 0.49222756 |
| 122 | CAMK1D | 0.49118615 |
| 123 | ERBB2 | 0.48416457 |
| 124 | DAPK2 | 0.47164414 |
| 125 | OBSCN | 0.46126952 |
| 126 | PLK4 | 0.45596348 |
| 127 | BRSK2 | 0.45497313 |
| 128 | PRKD2 | 0.45285241 |
| 129 | BRAF | 0.43686053 |
| 130 | PRKACA | 0.42932848 |
| 131 | NEK2 | 0.42043079 |
| 132 | WNK1 | 0.42021331 |
| 133 | CAMK4 | 0.38777169 |
| 134 | CSNK1D | 0.37353754 |
| 135 | MAP3K14 | 0.37027972 |
| 136 | PRKCA | 0.36609166 |
| 137 | MYLK | 0.36433404 |
| 138 | PRKAA1 | 0.36378417 |
| 139 | PRKCB | 0.36010356 |
| 140 | PKN1 | 0.35519942 |
| 141 | MARK2 | 0.35085871 |
| 142 | CSNK1G1 | 0.34104165 |
| 143 | CAMK1G | 0.33958520 |
| 144 | EPHA3 | 0.33296724 |
| 145 | MAP2K6 | 0.32098401 |
| 146 | STK38L | 0.31946664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.56483896 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.50540673 |
| 3 | Cocaine addiction_Homo sapiens_hsa05030 | 3.08226226 |
| 4 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.85510775 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.79538722 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.78686969 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.78080129 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.68258791 |
| 9 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.67198607 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.63458176 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.40147352 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 2.26610475 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.24764960 |
| 14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.24211513 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 2.22894386 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 2.21166120 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.18219804 |
| 18 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.17077412 |
| 19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.16186941 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.09432112 |
| 21 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 2.02316114 |
| 22 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.83139792 |
| 23 | Long-term potentiation_Homo sapiens_hsa04720 | 1.82061228 |
| 24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.81517691 |
| 25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.81458763 |
| 26 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.78388926 |
| 27 | Protein export_Homo sapiens_hsa03060 | 1.77161358 |
| 28 | Salivary secretion_Homo sapiens_hsa04970 | 1.71398809 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.68376882 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.68261824 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.63700582 |
| 32 | Alzheimers disease_Homo sapiens_hsa05010 | 1.61779012 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.60771910 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.57398390 |
| 35 | Renin secretion_Homo sapiens_hsa04924 | 1.56748800 |
| 36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.52262216 |
| 37 | Long-term depression_Homo sapiens_hsa04730 | 1.50911212 |
| 38 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.44319043 |
| 39 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.44216492 |
| 40 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.44043082 |
| 41 | Insulin secretion_Homo sapiens_hsa04911 | 1.43850739 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.33678097 |
| 43 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.31730822 |
| 44 | Huntingtons disease_Homo sapiens_hsa05016 | 1.25525091 |
| 45 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.23232247 |
| 46 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.21360460 |
| 47 | RNA polymerase_Homo sapiens_hsa03020 | 1.21137150 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.20709256 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 1.17510005 |
| 50 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.15814078 |
| 51 | Phototransduction_Homo sapiens_hsa04744 | 1.13544566 |
| 52 | Basal transcription factors_Homo sapiens_hsa03022 | 1.12162516 |
| 53 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.10744523 |
| 54 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.10400100 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.09360393 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08702996 |
| 57 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.07123421 |
| 58 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.06844214 |
| 59 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.06808192 |
| 60 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.04740962 |
| 61 | Gap junction_Homo sapiens_hsa04540 | 1.04358346 |
| 62 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.02866906 |
| 63 | Circadian rhythm_Homo sapiens_hsa04710 | 0.99037785 |
| 64 | Axon guidance_Homo sapiens_hsa04360 | 0.98150101 |
| 65 | RNA degradation_Homo sapiens_hsa03018 | 0.97606120 |
| 66 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92360529 |
| 67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91705104 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91101258 |
| 69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87089383 |
| 70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.84743176 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83948797 |
| 72 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83048176 |
| 73 | Homologous recombination_Homo sapiens_hsa03440 | 0.79195886 |
| 74 | Melanogenesis_Homo sapiens_hsa04916 | 0.79113858 |
| 75 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.76295379 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71494347 |
| 77 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71259533 |
| 78 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.71203145 |
| 79 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.70624289 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.70147725 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.69643654 |
| 82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69556789 |
| 83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.69184260 |
| 84 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.68413418 |
| 85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67428654 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.66934979 |
| 87 | Alcoholism_Homo sapiens_hsa05034 | 0.65741665 |
| 88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.65427679 |
| 89 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.65203966 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63466884 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61937162 |
| 92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60419821 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.60065505 |
| 94 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59871820 |
| 95 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59821850 |
| 96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58682694 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58189437 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56086308 |
| 99 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.55406157 |
| 100 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.54740329 |
| 101 | Phagosome_Homo sapiens_hsa04145 | 0.54629606 |
| 102 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53697005 |
| 103 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53027158 |
| 104 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52390307 |
| 105 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50935466 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.50147307 |
| 107 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50028229 |
| 108 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49891321 |
| 109 | Ribosome_Homo sapiens_hsa03010 | 0.49402826 |
| 110 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48761255 |
| 111 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.47947129 |
| 112 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46465119 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.44067014 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43077659 |
| 115 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42816122 |
| 116 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.40777687 |
| 117 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.40333791 |
| 118 | ABC transporters_Homo sapiens_hsa02010 | 0.39536766 |
| 119 | Purine metabolism_Homo sapiens_hsa00230 | 0.39520881 |
| 120 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.38504521 |
| 121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37970723 |
| 122 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.37748069 |
| 123 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.37502345 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36561079 |
| 125 | Retinol metabolism_Homo sapiens_hsa00830 | 0.36184115 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35305246 |
| 127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34900594 |
| 128 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34174760 |
| 129 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.33953152 |
| 130 | Melanoma_Homo sapiens_hsa05218 | 0.33516776 |
| 131 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.30294783 |
| 132 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29235299 |
| 133 | Mineral absorption_Homo sapiens_hsa04978 | 0.28116507 |
| 134 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27226271 |
| 135 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.26936431 |
| 136 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.26319913 |
| 137 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.26040109 |
| 138 | Glioma_Homo sapiens_hsa05214 | 0.25176158 |
| 139 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.21343834 |
| 140 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21235617 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19522215 |
| 142 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.18988541 |
| 143 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.18843259 |
| 144 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.18196272 |
| 145 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.17437211 |

